Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.

The research investigates the activity of certain metabolic enzymes, chiefly Cytochrome P450 3A (CYP3A), in the upper airways and liver of horses. It finds that despite lower gene and protein expression in the airways, the actual catalytic activity of CYP3A is substantially higher in these tissues compared to the liver, thanks to the presence of two other enzymes, NADPH P450 reductase and cytochrome b(5).

Overview of the Research

• This study primarily focuses on the gene and protein expression and the catalytic activity of a metabolic enzyme called Cytochrome P450 3A or CYP3A in different tissues of horses – the nasal olfactory and respiratory mucosa, the tracheal mucosa, and the liver.
• Additionally, the researchers also examined the activity of another enzyme known as NADPH P450 reductase, the amount of a component called cytochrome b(5), and the total CYP content in these tissues.
• To draw comparative insights, all the above parameters were also studied in liver tissue, using it as a control.

Main Findings

• The most significant outcome of the research is that the catalytic activity of CYP3A, which is the actual metabolic process performed by the enzyme, was substantially higher in the tissues of the upper airways than in the liver.
• However, when looking at the gene and protein expression, the liver showed a higher amount of CYP3A than the upper respiratory system. This creates an interesting dichotomy where the metabolic activity of the enzyme does not seem to match with its gene and protein expression levels.
• Further, the investigation revealed that the activity of NADPH P450 reductase, another enzyme involved in the metabolism process, and the level of cytochrome b(5) were higher in the tissues of the upper airways as compared to the liver.

Conclusion and Implications

• The data suggests that in horses, the metabolic process associated with CYP3A does not solely depend on the enzyme’s expression levels. Instead, it is largely influenced by the presence and adequate levels of NADPH P450 reductase and cytochrome b(5). This finding generates new insights into metabolic processes in mammals and could be foundational for future studies evaluating drug metabolism, toxicity, and pharmacokinetics.